PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Friends of Cancer Research, Washington, District of Columbia, United States of America.\', \'Reagan-Udall Foundation for the FDA, Washington, District of Columbia, United States of America.\', \'Health Catalyst, Salt Lake City, Utah, United States of America.\', \'Gilead Science, Inc. Foster City, California, United States of America.\', \'COTA, Inc., Boston, Massachusetts, United States of America.\', \'Syapse, San Francisco, California, United States of America.\', \'Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, Massachusetts, United States of America.\', \'Department of Medicine, Brigham and Women\'s Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.\', \'Dascena, Oakland, California, United States of America.\', \'Aetion, New York, New York, United States of America.\', \'Division of Outcomes and Value Research, John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States of America.\', \'VA Connecticut Healthcare System, West Haven, Connecticut, United States of America.\', \'Yale University Schools of Medicine and Public Health, New Haven, Connecticut, United States of America.\', \'HealthVerity, Philadelphia, Pennsylvania, United States of America.\', \'TriNetX, Cambridge, Massachusetts, United States of America.\', \'National Center for Computational Sciences Oak Ridge National Laboratory, Oak Ridge, Tennessee, United States of America.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1371/journal.pone.0248128
?:hasPublicationType
?:journal
  • PloS one
is ?:pmid of
?:pmid
?:pmid
  • 33730088
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 241
?:title
  • COVID-19 Evidence Accelerator: A parallel analysis to describe the use of Hydroxychloroquine with or without Azithromycin among hospitalized COVID-19 patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33730088>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33730088>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all